Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Update on Preclinical Models of Cancer Therapy-Related Cardiac Dysfunction: Challenges and Perspectives. A Scientific Statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-Oncology, and the ESC Working Group on Cellular Biology of the Heart

European Journal of Heart Failure(2025)10.1002/ejhf.3636Source: DataRank Database

Update on Preclinical Models of Cancer Therapy-Related Cardiac Dysfunction: Challenges and Perspectives. A Scientific Statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-Oncology, and the ESC Working Group on Cellular Biology of the Heart is a research paper published in European Journal of Heart Failure (2025). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)Impact (FWCI 9.40)OA: hybridTopics (55)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (23)

Pietro Ameri ORCID,Aarti Asnani ORCID,Edoardo Bertero ORCID,Rudolf A. de Boer ORCID,Dimitrios Farmakis ORCID

Live enrichment

PubMed:40069106 PMC:PMC12260315 OpenAlex:https://openalex.org/W4408383416

European Research Council

Grant: 818715

SECRETED FACTORS IN CARDIAC REMODELING PROVOKE TUMORIGENESIS AND END ORGAN DAMAGE IN HEART FAILURE

NHLBI NIH HHS

Grant: R01 HL163172

European Research Council

Grant: 101045236

Dynamic engIneered heart tiSsue to Study intEr-individual susCeptibily and improve Treatment of Heart Failure

NHLBI NIH HHS

Grant: R01 HL157530

NHLBI NIH HHS

Grant: R01 HL166541

European Commission

Grant: 819775

Novel mitochondria-targeted therapies for cancer treatment-induced cardiotoxicity

National Institutes of Health

Grant: 5R01HL157530-03

A Multi-Dimensional Linked Registry to Identify Biological, Clinical, Health System, and Socioeconomic Risk Factors for COVID-19-Related Cardiovascular Events

National Institutes of Health

Grant: 5R01HL166541-03

Mitochondrial iron export therapy for doxorubicin-induced cardiotoxicity

European Commission

Grant: 759248

Endothelial RNA Modifications in Vascular Homeostasis and Disease

European Commission

Grant: 945118

Remote Ischemic Conditioning in Lymphoma Patients Receiving Anthracyclines.

National Institutes of Health

Grant: 5R01HL163172-03

Hemopexin as an Early Biomarker of Anthracycline Cardiac Toxicity

European Commission

Grant: 847012

Unravelling the molecular and cellular mechanism of metastasis

FWCI

9.40

Citation Percentile

1.0%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ejhf.3636

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ejhf.3636

publisherhttps://academic.oup.com/eurjhf/article-pdf/27/6/1028/66824826/eurjhf_27_6_1028.pdf

journalhttps://doi.org/10.1002/ejhf.3636

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40069106

Fields of Study

Chemotherapy-induced cardiotoxicity and mitigationCardiac Fibrosis and RemodelingCAR-T cell therapy research03 medical and health sciences0302 clinical medicine

MeSH Terms

Cardio-OncologyAnimalsAntineoplastic AgentsCardiologyDisease Models, AnimalHeart FailureHumansMedical OncologyNeoplasmsSocieties, MedicalCardiotoxicity

Keywords

MedicineHeart failureStatement (logic)Cancer therapyCancerInternal medicineCardiologyImmunotherapyCardiotoxicityAnticancer TherapyPreclinical ModelsCardiac & Cardiovascular SystemsAntineoplastic AgentsMedical OncologyCARDIOMYOCYTESEVENTSSDG 3 - Good Health and Well-beingNeoplasmsCARDIOVASCULAR TOXICITIESHumansAnimalsIMMUNE CHECKPOINT INHIBITORS1102 Cardiorespiratory Medicine and HaematologyTHE HEART AND CANCERSocieties, MedicalScience & TechnologyRECEPTORTUMOR-GROWTHIPILIMUMABANTHRACYCLINE-INDUCED CARDIOTOXICITYAnticancer therapy; Cancer; Cardiotoxicity; Immunotherapy; Preclinical modelsDisease Models, AnimalCardiovascular System & HematologyCardiovascular System & CardiologyT-CELLSSURVIVALCardio-Oncology3201 Cardiovascular medicine and haematologyLife Sciences & Biomedicine

Sustainable Development Goals

SDG 0: Good health and well-being